Microorganisms | Strategies | Titer | References |
---|---|---|---|
E. coli | Using recombinant E. coli expressing CYP109B1 from B. subtilis as whole cell biocatalyst for the oxidation of in vitro fed (+)-valencene | 3.32Â mg/L | [17] |
S. cerevisiae | Using yeast WAT11 expressing CYP71D51v2 from N. tabacum as whole cell biocatalyst for the oxidation of in vitro fed (+)-valencene | 3.00Â mg/L | [10] |
Chaetomium globosum | Using submerged cultures of C. globosum as whole cell biocatalyst for the oxidation of in vitro fed (+)-valencene | 25.00Â mg/L | [39] |
Yarrowia lipolytica | Using Y. lipolytica as the whole cell biocatalyst for the oxidation of (+)-valencene (3.3Â g/L) in the fed orange essential oil in a three phase partitioning bioreactor | 852.30Â mg/L | [38] |
S. cerevisiae | Co-expression of (+)-valencene synthase Cstps1 with a chicory cytochrome P450 mono-oxygenase CYP71AV8 | 0.04Â mg/L | [18] |
S. cerevisiae | Co-expression of (+)-valencene synthase CnVS with a (+)-valencene oxidase CYP706M1 from C. nootkatensis | 0.144Â mg/L | [20] |
P. pastoris | Co-expression of CnVS, HPO and ADH-C-3 in combination with overexpression tHMG1 in P. pastoris | 35.00Â mg/L (flask fermentation) 208.00Â mg/L (fed-batch fermentation) | [23] |
S. cerevisiae | Combining CnVS overexpression with various MVA pathway engineering approaches including the expression of CnVS and ERG20 as fused proteins, overexpression of tHMG1, and downregulating the ERG9 competitive pathway; achieve (+)-valencene oxidation by simultaneous overexpression of HPO and dehydrogenases ZSD1 | 59.78Â mg/L | The present study |